» Articles » PMID: 25038487

Liver Sinusoidal Endothelial Dysfunction After LPS Administration: a Role for Inducible-nitric Oxide Synthase

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2014 Jul 20
PMID 25038487
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Sepsis is associated with microvascular dysfunction, which contributes to organ failure. Intrahepatic endothelial dysfunction occurs after exposure to lipopolysaccharide (LPS). The upregulation of inducible nitric oxide synthase (iNOS) has been shown to contribute to systemic vascular dysfunction after LPS administration. However, little is known about the effects of iNOS induction on the liver microcirculation. This study aimed at exploring, in the isolated rat liver perfusion model, the role of iNOS induction in liver microvascular dysfunction associated with endotoxemia.

Methods: All experiments were conducted in male Wistar rats, after 24 h of LPS (5 mg/kg i.p.) or saline administration in the presence or absence of the iNOS inhibitor 1400 W (3 mg/kg i.p.), administered 3 and 23 h after LPS/saline injection. Liver microvascular function was assessed by isolated liver perfusion, followed by molecular studies and liver function tests.

Results: At 24 h, LPS induced liver endothelial dysfunction, as shown by a decreased vasodilatory response to acetylcholine and decreased eNOS phosphorylation at Ser(1176). This was associated with liver injury, assessed by an increase in liver transaminases and decreased indocyanin green clearance, and increased nitrooxidative stress. iNOS inhibition prevented liver endothelial dysfunction, blunted the development of liver injury and attenuated LPS-induced nitrooxidative stress.

Conclusions: iNOS upregulation contributes to liver microvascular dysfunction in endotoxemia. This suggests that this mechanism deserves further exploration in studies addressing liver protection in the context of severe acute bacterial infection.

Citing Articles

Analysis of the prognostic efficacy of syndecan-1 for patients with ACLF and its functional role in liver regeneration.

He Y, Zhang X, Yao Y, Li J, Fu S, Feng Y BMC Med. 2025; 23(1):104.

PMID: 39985044 PMC: 11846419. DOI: 10.1186/s12916-025-03931-4.


[Liver diseases in the intensive care unit].

Roedl K, Fuhrmann V Med Klin Intensivmed Notfmed. 2024; 119(6):449-457.

PMID: 38937335 DOI: 10.1007/s00063-024-01157-5.


Gastro‑oesophageal reflux disease in liver cirrhosis: Possible pathogenesis and clinical intervention (Review).

Yu F, Zhu Y, Li N, Fu H, Jiang Z, Zhang X Exp Ther Med. 2023; 26(3):414.

PMID: 37559931 PMC: 10407984. DOI: 10.3892/etm.2023.12113.


Role of Gut Microbiota and Oxidative Stress in the Progression of Transplant-Related Complications following Hematopoietic Stem Cell Transplantation.

Chi M, Jiang T, He X, Peng H, Li Y, Zhang J Oxid Med Cell Longev. 2023; 2023:3532756.

PMID: 37113743 PMC: 10129428. DOI: 10.1155/2023/3532756.


Modulation of the Acute Inflammatory Response Induced by the Lipopolysaccharide through the Interaction of Pentoxifylline and Florfenicol in a Rabbit Model.

Cazanga V, Palma C, Casanova T, Rojas D, Barrera K, Valenzuela C Antibiotics (Basel). 2023; 12(4).

PMID: 37107001 PMC: 10135147. DOI: 10.3390/antibiotics12040639.